Lymphoma

FDA Approves CAR T-Cell Therapy to Treat Adults With Certain Types of Large B-Cell Lymphoma

On October 19, the U.S. Food and Drug Administration approved axicabtagene ciloleucel (Yescarta), a cell-based gene therapy...

Skin Cancer

Combination Therapy for Patients With Advanced Unresectable Melanoma

A phase II study has shown that the addition of the oncolytic viral agent talimogene laherparepvec...

Kidney Cancer

Nivolumab Plus Ipilimumab vs Sunitinib Alone as First-Line Therapy for Metastatic Renal Cell Carcinoma

A change in paradigm may be on the horizon for the treatment of metastatic renal cell carcinoma. According to...


Advertisement

More Top Stories

Breast Cancer
Survivorship

Matteo Lambertini, MD, on Pregnancy in Breast Cancer Patients: Results From a Multicenter Study

ASCO’s QOPI Certification Program™ Recognizes Three Oncology Practices in Spain

ASCO has announced that the first three practices in Spain have received Quality Oncology Practice Initiative (QOPI®) certification through the QOPI Certification Program™, LLC (QCP). The accreditations were given on September 8, at the European Society for Medical Oncology (ESMO) 2017 Congress in...

Advertisement

Survival in Patients Treated With Adjuvant Chemoradiotherapy After Resection of Gastric Cancer

In the CALGB 80101/Alliance trial, no difference in overall survival was found for adjuvant chemoradiotherapy with epirubicin, cisplatin, and fluorouracil (ECF) vs fluorouracil and leucovorin (5-FU/LV) after curative resection of gastric cancer. The findings were reported in the Journal of Clinical ...

Prostate Cancer

Cora N. Sternberg, MD, on Prostate Cancer Treatment Findings: Expert Perspective

Issues in Oncology
Health-Care Policy
Legislation

Cancer Policy Priorities Front and Center on Capitol Hill

On September 27 and 28, more than 100 ASCO volunteers headed to Capitol Hill to participate in the 2nd Annual ASCO Advocacy Summit. During the Summit, advocates met with members of Congress and staff to educate them on critical issues affecting patients and providers and to encourage policymakers...

Educate and Support Your Patients With ASCO Answers Materials

Provide your patients with ASCO-approved information on cancer.  ASCO Answers materials are available as fact sheets and booklets, covering many types of cancer as well as treatments and side effects.  Order printed copies online today through the ASCO Bookstore at www.cancer.net/estore. Enjoy...

Sperm Banking for Adolescent Males With Newly Diagnosed Cancer

In a study reported in the Journal of Clinical Oncology, Klosky et al identified factors associated with sperm banking among adolescent males with newly diagnosed cancer who were at increased risk for treatment-related fertility loss. The study included 146 adolescents aged 13 to 22 years (mean...

Skin Cancer

Caroline Robert, MD, PhD, on Melanoma: Treatment With Nivolumab and Ipilimumab

Breast Cancer

For Breast Cancer Specialist Ann H. Partridge, MD, MPH, Medicine Is a Family Tradition

Breast cancer specialist Ann H. Partridge, MD, MPH, was born in Manhasset, Long Island, and grew up several miles east in Muttontown, New York. Since tiny Muttontown didn’t have its own school system, Dr. Partridge went to high school in nearby Locust Valley, a town on Long Island’s North Shore,...

Advertisement

IASLC 2017: First-Line Pembrolizumab Increases Overall Survival vs Chemotherapy in Metastatic NSCLC With High Levels of PD-L1

Updated overall survival findings from the phase III KEYNOTE-024 trial evaluating pembrolizumab (Keytruda) as a first-line monotherapy in patients with non–small cell lung cancer (NSCLC) whose tumors express high levels of programmed cell death ligand 1 (PD-L1) were presented at the...